Literature DB >> 8266398

Immunology of leprosy.

W J Britton1.   

Abstract

The host immune response to Mycobacterium leprae is critical for control of the infection but also responsible for the immunopathological damage to skin and nerves. The complex and varied immune responses to the organism are the basis for the clinical spectrum of disease ranging from tuberculoid to lepromatous leprosy. The cellular interactions underlying this spectrum are discussed and the antigenic components of the bacillus briefly reviewed. M. leprae has evolved a variety of mechanisms to avoid macrophage bactericidal mechanisms. These result in the persistence of bacilli and the release of cytokines leading to chronic granulomatous inflammation. The immune response to M. leprae is dynamic and spontaneous variations in cellular reactivity occur with time leading to type I and II leprosy reactions. The factors which preset the host immune response to a tuberculoid or lepromatous pattern and which precipitate reactional episodes remain to be elucidated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8266398     DOI: 10.1016/0035-9203(93)90066-y

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  10 in total

1.  Specific serological diagnosis of leprosy with a recombinant Mycobacterium leprae protein purified from a rapidly growing mycobacterial host.

Authors:  J A Triccas; P W Roche; W J Britton
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

Review 2.  Why intracellular parasitism need not be a degrading experience for Mycobacterium.

Authors:  D G Russell; S Sturgill-Koszycki; T Vanheyningen; H Collins; U E Schaible
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  1997-09-29       Impact factor: 6.237

Review 3.  Recent advances in tropical medicine.

Authors:  D N Lockwood; G Pasvol
Journal:  BMJ       Date:  1994-06-11

4.  A 35-kilodalton protein is a major target of the human immune response to Mycobacterium leprae.

Authors:  J A Triccas; P W Roche; N Winter; C G Feng; C R Butlin; W J Britton
Journal:  Infect Immun       Date:  1996-12       Impact factor: 3.441

5.  Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice.

Authors:  A Ciurea; P Klenerman; L Hunziker; E Horvath; B Odermatt; A F Ochsenbein; H Hengartner; R M Zinkernagel
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-12       Impact factor: 11.205

6.  T cell clones from a non-leprosy exposed subject recognize the Mycobacterium leprae 18-kD protein.

Authors:  E Adams; A Basten; R Prestidge; W J Britton
Journal:  Clin Exp Immunol       Date:  1995-10       Impact factor: 4.330

7.  Leprosy reactions: The predictive value of Mycobacterium leprae-specific serology evaluated in a Brazilian cohort of leprosy patients (U-MDT/CT-BR).

Authors:  Emerith Mayra Hungria; Samira Bührer-Sékula; Regiane Morillas de Oliveira; Lúcio Cartaxo Aderaldo; Araci de Andrade Pontes; Rossilene Cruz; Heitor de Sá Gonçalves; Maria Lúcia Fernandes Penna; Gerson Oliveira Penna; Mariane Martins de Araújo Stefani
Journal:  PLoS Negl Trop Dis       Date:  2017-02-21

Review 8.  Rapidly Growing Mycobacterium Species: The Long and Winding Road from Tuberculosis Vaccines to Potent Stress-Resilience Agents.

Authors:  Mattia Amoroso; Dominik Langgartner; Christopher A Lowry; Stefan O Reber
Journal:  Int J Mol Sci       Date:  2021-11-29       Impact factor: 5.923

9.  An in vitro model of Mycobacterium leprae induced granuloma formation.

Authors:  Hongsheng Wang; Yumi Maeda; Yasuo Fukutomi; Masahiko Makino
Journal:  BMC Infect Dis       Date:  2013-06-20       Impact factor: 3.090

Review 10.  Leprosy in Denmark 1980-2010: a review of 15 cases.

Authors:  Huma Aftab; Susanne D Nielsen; Ib C Bygbjerg
Journal:  BMC Res Notes       Date:  2016-01-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.